Androgen therapy in inherited bone marrow failure syndromes: analysis from the Canadian Inherited Marrow Failure Registry

Summary Progressive cytopenia is a serious complication among paediatric patients with inherited bone marrow failure syndromes (IBMFS). Androgens have been used to improve blood counts in different bone marrow failure conditions. Little is known about efficacy and toxicity with new androgens (i.e.,...

Full description

Saved in:
Bibliographic Details
Published inBritish journal of haematology Vol. 189; no. 5; pp. 976 - 981
Main Authors Català, Albert, Ali, Salah S., Cuvelier, Geoffrey D. E., Steele, MacGregor, Klaassen, Robert J., Fernandez, Conrad V., Pastore, Yves D., Abish, Sharon, Rayar, Meera, Jardine, Lawrence, Breakey, Vicky R., Brossard, Josee, Sinha, Roona, Silva, Mariana, Goodyear, Lisa, Lipton, Jeffrey H., Michon, Bruno, Corriveau‐Bourque, Catherine, Sung, Lillian, Lauhasurayotin, Supanun, Zlateska, Bozana, Cada, Michaela, Dror, Yigal
Format Journal Article
LanguageEnglish
Published England Blackwell Publishing Ltd 01.06.2020
Subjects
Online AccessGet full text
ISSN0007-1048
1365-2141
1365-2141
DOI10.1111/bjh.16445

Cover

Abstract Summary Progressive cytopenia is a serious complication among paediatric patients with inherited bone marrow failure syndromes (IBMFS). Androgens have been used to improve blood counts in different bone marrow failure conditions. Little is known about efficacy and toxicity with new androgens (i.e., danazol) in different types of IBMFS. We identified 29 patients from the Canadian Inherited Marrow Failure Registry, who received oxymetholone or danazol. Sixteen (55%) had haematological response including patients with unclassified IBMFS (45%). Danazol showed a better toxicity profile and similar efficacy compared to oxymetholone. Androgens are an effective and safe option to ameliorate bone marrow failure in IBMFS.
AbstractList Progressive cytopenia is a serious complication among paediatric patients with inherited bone marrow failure syndromes (IBMFS). Androgens have been used to improve blood counts in different bone marrow failure conditions. Little is known about efficacy and toxicity with new androgens (i.e., danazol) in different types of IBMFS. We identified 29 patients from the Canadian Inherited Marrow Failure Registry, who received oxymetholone or danazol. Sixteen (55%) had haematological response including patients with unclassified IBMFS (45%). Danazol showed a better toxicity profile and similar efficacy compared to oxymetholone. Androgens are an effective and safe option to ameliorate bone marrow failure in IBMFS.
Summary Progressive cytopenia is a serious complication among paediatric patients with inherited bone marrow failure syndromes (IBMFS). Androgens have been used to improve blood counts in different bone marrow failure conditions. Little is known about efficacy and toxicity with new androgens (i.e., danazol) in different types of IBMFS. We identified 29 patients from the Canadian Inherited Marrow Failure Registry, who received oxymetholone or danazol. Sixteen (55%) had haematological response including patients with unclassified IBMFS (45%). Danazol showed a better toxicity profile and similar efficacy compared to oxymetholone. Androgens are an effective and safe option to ameliorate bone marrow failure in IBMFS.
Progressive cytopenia is a serious complication among paediatric patients with inherited bone marrow failure syndromes (IBMFS). Androgens have been used to improve blood counts in different bone marrow failure conditions. Little is known about efficacy and toxicity with new androgens (i.e., danazol) in different types of IBMFS. We identified 29 patients from the Canadian Inherited Marrow Failure Registry, who received oxymetholone or danazol. Sixteen (55%) had haematological response including patients with unclassified IBMFS (45%). Danazol showed a better toxicity profile and similar efficacy compared to oxymetholone. Androgens are an effective and safe option to ameliorate bone marrow failure in IBMFS.Progressive cytopenia is a serious complication among paediatric patients with inherited bone marrow failure syndromes (IBMFS). Androgens have been used to improve blood counts in different bone marrow failure conditions. Little is known about efficacy and toxicity with new androgens (i.e., danazol) in different types of IBMFS. We identified 29 patients from the Canadian Inherited Marrow Failure Registry, who received oxymetholone or danazol. Sixteen (55%) had haematological response including patients with unclassified IBMFS (45%). Danazol showed a better toxicity profile and similar efficacy compared to oxymetholone. Androgens are an effective and safe option to ameliorate bone marrow failure in IBMFS.
Author Zlateska, Bozana
Brossard, Josee
Goodyear, Lisa
Cada, Michaela
Lipton, Jeffrey H.
Jardine, Lawrence
Silva, Mariana
Ali, Salah S.
Cuvelier, Geoffrey D. E.
Michon, Bruno
Lauhasurayotin, Supanun
Steele, MacGregor
Abish, Sharon
Klaassen, Robert J.
Dror, Yigal
Sinha, Roona
Català, Albert
Fernandez, Conrad V.
Sung, Lillian
Corriveau‐Bourque, Catherine
Breakey, Vicky R.
Pastore, Yves D.
Rayar, Meera
Author_xml – sequence: 1
  givenname: Albert
  orcidid: 0000-0003-0133-1752
  surname: Català
  fullname: Català, Albert
  organization: The Hospital for Sick Children
– sequence: 2
  givenname: Salah S.
  surname: Ali
  fullname: Ali, Salah S.
  organization: The Hospital for Sick Children
– sequence: 3
  givenname: Geoffrey D. E.
  surname: Cuvelier
  fullname: Cuvelier, Geoffrey D. E.
  organization: CancerCare Manitoba
– sequence: 4
  givenname: MacGregor
  surname: Steele
  fullname: Steele, MacGregor
  organization: Alberta Children's Hospital
– sequence: 5
  givenname: Robert J.
  surname: Klaassen
  fullname: Klaassen, Robert J.
  organization: Children's Hospital of Eastern Ontario
– sequence: 6
  givenname: Conrad V.
  surname: Fernandez
  fullname: Fernandez, Conrad V.
  organization: IWK Health Centre
– sequence: 7
  givenname: Yves D.
  surname: Pastore
  fullname: Pastore, Yves D.
  organization: CHU Sainte‐Justine
– sequence: 8
  givenname: Sharon
  surname: Abish
  fullname: Abish, Sharon
  organization: Montreal Children's Hospital
– sequence: 9
  givenname: Meera
  surname: Rayar
  fullname: Rayar, Meera
  organization: UBC & B.C. Children's Hospital
– sequence: 10
  givenname: Lawrence
  surname: Jardine
  fullname: Jardine, Lawrence
  organization: London Health Sciences Centre
– sequence: 11
  givenname: Vicky R.
  surname: Breakey
  fullname: Breakey, Vicky R.
  organization: McMaster University
– sequence: 12
  givenname: Josee
  surname: Brossard
  fullname: Brossard, Josee
  organization: Centre Hospitalier Universitaire
– sequence: 13
  givenname: Roona
  surname: Sinha
  fullname: Sinha, Roona
  organization: Royal University Hospital
– sequence: 14
  givenname: Mariana
  surname: Silva
  fullname: Silva, Mariana
  organization: Kingston General Hospital
– sequence: 15
  givenname: Lisa
  surname: Goodyear
  fullname: Goodyear, Lisa
  organization: Janeway Child Health Centre
– sequence: 16
  givenname: Jeffrey H.
  surname: Lipton
  fullname: Lipton, Jeffrey H.
  organization: University of Toronto
– sequence: 17
  givenname: Bruno
  surname: Michon
  fullname: Michon, Bruno
  organization: Centre Hospitalier Universitaire de Quebec
– sequence: 18
  givenname: Catherine
  surname: Corriveau‐Bourque
  fullname: Corriveau‐Bourque, Catherine
  organization: University of Alberta
– sequence: 19
  givenname: Lillian
  surname: Sung
  fullname: Sung, Lillian
  organization: The Hospital for Sick Children
– sequence: 20
  givenname: Supanun
  surname: Lauhasurayotin
  fullname: Lauhasurayotin, Supanun
  organization: The Hospital for Sick Children
– sequence: 21
  givenname: Bozana
  surname: Zlateska
  fullname: Zlateska, Bozana
  organization: The Hospital for Sick Children
– sequence: 22
  givenname: Michaela
  surname: Cada
  fullname: Cada, Michaela
  organization: The Hospital for Sick Children
– sequence: 23
  givenname: Yigal
  orcidid: 0000-0003-3953-1477
  surname: Dror
  fullname: Dror, Yigal
  organization: University of Toronto
BackLink https://www.ncbi.nlm.nih.gov/pubmed/32128787$$D View this record in MEDLINE/PubMed
BookMark eNp9kV1LwzAUhoNM3Ide-Ack4I1ebMtX09a7OZybTATR65I26ZbRpTNpGf33Zm7uYqAhkHB43vdw3tMFLVMaBcA1RgPszzBdLQeYMxacgQ6mPOgTzHALdBBCYR8jFrVB17kVQpiiAF-ANiWYRGEUdkAzMtKWC2VgtVRWbBqojb_-ryslYeobwbWwttzCXOiitgq6ZidZK_cAhRFF47SDuS_sHODYl6QWBs6OHq97-eQgf1cL7SrbXILzXBROXR3eHvicPH2Mp_352_NsPJr3MxpFfhSeESVkmAc5klkcxAHPJM2o5EhwHpKc8lzGjKdSIowIZSnxEQgc0EihKA5oD9ztfTe2_KqVq5K1dpkqCmFUWbuE0BBjxghjHr09QVdlbf2MnmIo5jRieGd4c6DqdK1ksrHaJ9Qkv6F64H4PZLZ0zqr8iGCU7BaW-IUlPwvz7PCEzXQlKl2ayvrA_lNsdaGav62Tx5fpXvEN7ZCmcg
CitedBy_id crossref_primary_10_3324_haematol_2023_282935
crossref_primary_10_1007_s10875_020_00829_z
crossref_primary_10_1016_j_blre_2023_101132
crossref_primary_10_3390_ijms21197196
crossref_primary_10_1182_blood_2023020875
crossref_primary_10_1016_j_beha_2021_101282
crossref_primary_10_1182_bloodadvances_2021004205
crossref_primary_10_1016_j_blre_2024_101225
crossref_primary_10_1182_bloodadvances_2021006490
Cites_doi 10.3109/08880018.2015.1129567
10.1016/S0149-2918(01)80114-4
10.1002/pbc.24617
10.1182/blood-2008-09-178871
10.1007/s12185-016-1951-0
10.1111/bjh.12748
10.1002/ajh.20183
10.1007/s00228-009-0771-z
10.1016/j.bcmd.2011.11.006
10.1007/s12185-012-1249-9
10.1182/asheducation-2017.1.96
10.1111/bjh.12432
10.1056/NEJMoa1515319
ContentType Journal Article
Copyright 2020 British Society for Haematology and John Wiley & Sons Ltd
2020 British Society for Haematology and John Wiley & Sons Ltd.
Copyright © 2020 John Wiley & Sons Ltd
Copyright_xml – notice: 2020 British Society for Haematology and John Wiley & Sons Ltd
– notice: 2020 British Society for Haematology and John Wiley & Sons Ltd.
– notice: Copyright © 2020 John Wiley & Sons Ltd
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7T5
H94
K9.
7X8
DOI 10.1111/bjh.16445
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Immunology Abstracts
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Immunology Abstracts
MEDLINE - Academic
DatabaseTitleList CrossRef

AIDS and Cancer Research Abstracts
MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1365-2141
EndPage 981
ExternalDocumentID 32128787
10_1111_bjh_16445
BJH16445
Genre shortCommunication
Journal Article
GeographicLocations Canada
GeographicLocations_xml – name: Canada
GroupedDBID ---
.3N
.55
.GA
.GJ
.Y3
05W
0R~
10A
1KJ
1OB
1OC
23N
24P
31~
33P
36B
3O-
3SF
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5HH
5LA
5RE
5VS
66C
6J9
6P2
702
7PT
8-0
8-1
8-3
8-4
8-5
8F7
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AAHQN
AAIPD
AAKAS
AAMNL
AANHP
AANLZ
AAONW
AASGY
AAXRX
AAYCA
AAYEP
AAZKR
ABCQN
ABCUV
ABEML
ABJNI
ABLJU
ABOCM
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACFBH
ACGFO
ACGFS
ACGOF
ACMXC
ACPOU
ACPRK
ACRPL
ACSCC
ACXBN
ACXQS
ACYXJ
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADNMO
ADOZA
ADXAS
ADZCM
ADZMN
ADZOD
AEEZP
AEGXH
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFEBI
AFFNX
AFFPM
AFGKR
AFPWT
AFRAH
AFWVQ
AFZJQ
AHBTC
AHEFC
AI.
AIACR
AIAGR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
ASPBG
ATUGU
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CAG
COF
CS3
D-6
D-7
D-E
D-F
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
EBS
EGARE
EJD
EMOBN
ESX
EX3
F00
F01
F04
F5P
FEDTE
FUBAC
FZ0
G-S
G.N
GODZA
H.X
HF~
HGLYW
HVGLF
HZI
HZ~
IH2
IHE
IX1
J0M
J5H
K48
KBYEO
L7B
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N4W
N9A
NF~
O66
O9-
OIG
OK1
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
PALCI
Q.N
Q11
QB0
R.K
RIWAO
RJQFR
ROL
RX1
SAMSI
SUPJJ
TEORI
UB1
V8K
V9Y
VH1
W8V
W99
WBKPD
WHWMO
WIH
WIJ
WIK
WIN
WOHZO
WOW
WQJ
WRC
WUP
WVDHM
WXI
WXSBR
X7M
XG1
YFH
YOC
YUY
ZGI
ZXP
ZZTAW
~IA
~WT
AAYXX
AEYWJ
AGHNM
AGQPQ
AGYGG
CITATION
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
CGR
CUY
CVF
ECM
EIF
NPM
7T5
H94
K9.
7X8
ID FETCH-LOGICAL-c3885-26c2ead7f5f0dc95956cd3c3d60a6672f36fd946bdd010234b2136a1538e08953
IEDL.DBID DR2
ISSN 0007-1048
1365-2141
IngestDate Fri Jul 11 12:04:02 EDT 2025
Fri Jul 25 09:53:32 EDT 2025
Mon Jul 21 05:50:51 EDT 2025
Thu Apr 24 22:50:34 EDT 2025
Tue Jul 01 00:53:46 EDT 2025
Wed Jan 22 16:33:29 EST 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 5
Keywords bone marrow failure
Fanconi anaemia
dyskeratosis congenita
androgens
danazol
Language English
License 2020 British Society for Haematology and John Wiley & Sons Ltd.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3885-26c2ead7f5f0dc95956cd3c3d60a6672f36fd946bdd010234b2136a1538e08953
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0003-0133-1752
0000-0003-3953-1477
OpenAccessLink https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bjh.16445
PMID 32128787
PQID 2409638415
PQPubID 36395
PageCount 6
ParticipantIDs proquest_miscellaneous_2371144244
proquest_journals_2409638415
pubmed_primary_32128787
crossref_primary_10_1111_bjh_16445
crossref_citationtrail_10_1111_bjh_16445
wiley_primary_10_1111_bjh_16445_BJH16445
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate June 2020
2020-06-00
20200601
PublicationDateYYYYMMDD 2020-06-01
PublicationDate_xml – month: 06
  year: 2020
  text: June 2020
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: Oxford
PublicationTitle British journal of haematology
PublicationTitleAlternate Br J Haematol
PublicationYear 2020
Publisher Blackwell Publishing Ltd
Publisher_xml – name: Blackwell Publishing Ltd
References 2010; 66
2004; 77
2017; 2017
2013; 97
2016; 374
2013; 162
2016; 103
2012; 48
2014; 165
2001; 23
2014; 61
2009; 114
2016; 33
e_1_2_6_10_1
e_1_2_6_9_1
e_1_2_6_8_1
e_1_2_6_5_1
e_1_2_6_4_1
e_1_2_6_7_1
e_1_2_6_6_1
e_1_2_6_13_1
e_1_2_6_14_1
e_1_2_6_3_1
e_1_2_6_11_1
e_1_2_6_2_1
e_1_2_6_12_1
References_xml – volume: 162
  start-page: 854
  year: 2013
  end-page: 856
  article-title: Haematological recovery in dyskeratosis congenita patients treated with danazol
  publication-title: British Journal of Haematology
– volume: 66
  start-page: 419
  year: 2010
  end-page: 426
  article-title: The effect of long‐term danazol prophylaxis on liver function in hereditary angioedema—a longitudinal study
  publication-title: European Journal of Clinical Pharmacology
– volume: 165
  start-page: 349
  year: 2014
  end-page: 357
  article-title: Response to androgen therapy in patients with dyskeratosis congenita
  publication-title: British Journal of Haematology
– volume: 33
  start-page: 5
  year: 2016
  end-page: 12
  article-title: Androgen therapy in Fanconi anemia: a retrospective analysis of 30 years in Germany
  publication-title: Pediatric Hematology and Oncology
– volume: 2017
  start-page: 96
  year: 2017
  end-page: 101
  article-title: Treatment of inherited bone marrow failure syndromes beyond transplantation
  publication-title: Hematology. American Society of Hematology. Education Program
– volume: 48
  start-page: 128
  year: 2012
  end-page: 131
  article-title: Treatment of the bone marrow failure in Fanconi anemia patients with danazol
  publication-title: Blood Cells, Molecules, and Diseases
– volume: 103
  start-page: 373
  year: 2016
  end-page: 379
  article-title: Allogeneic hematopoietic stem cell transplantation for inherited bone marrow failure syndromes
  publication-title: International Journal of Hematology
– volume: 61
  start-page: 11
  year: 2014
  end-page: 19
  article-title: Oxandrolone for the treatment of bone marrow failure in Fanconi anemia
  publication-title: Pediatric Blood & Cancer
– volume: 374
  start-page: 1922
  year: 2016
  end-page: 1931
  article-title: Danazol treatment for telomere diseases
  publication-title: New England Journal of Medicine
– volume: 114
  start-page: 2236
  year: 2009
  end-page: 2243
  article-title: Sex hormones, acting on the TERT gene, increase telomerase activity in human primary hematopoietic cells
  publication-title: Blood
– volume: 23
  start-page: 1355
  year: 2001
  end-page: 1390
  article-title: A review of the chemistry, biological action, and clinical applications of anabolic‐androgenic steroids
  publication-title: Clinical Therapeutics
– volume: 97
  start-page: 20–29 A
  year: 2013
  article-title: Inherited bone marrow failure syndromes in 2012
  publication-title: International Journal of Hematology
– volume: 77
  start-page: 257
  year: 2004
  end-page: 267
  article-title: Androgens and liver tumors: Fanconi’s anemia and non‐Fanconi’s conditions
  publication-title: American Journal of Hematology
– ident: e_1_2_6_8_1
  doi: 10.3109/08880018.2015.1129567
– ident: e_1_2_6_12_1
  doi: 10.1016/S0149-2918(01)80114-4
– ident: e_1_2_6_9_1
  doi: 10.1002/pbc.24617
– ident: e_1_2_6_3_1
  doi: 10.1182/blood-2008-09-178871
– ident: e_1_2_6_4_1
  doi: 10.1007/s12185-016-1951-0
– ident: e_1_2_6_7_1
  doi: 10.1111/bjh.12748
– ident: e_1_2_6_14_1
  doi: 10.1002/ajh.20183
– ident: e_1_2_6_5_1
  doi: 10.1007/s00228-009-0771-z
– ident: e_1_2_6_11_1
  doi: 10.1016/j.bcmd.2011.11.006
– ident: e_1_2_6_10_1
  doi: 10.1007/s12185-012-1249-9
– ident: e_1_2_6_2_1
  doi: 10.1182/asheducation-2017.1.96
– ident: e_1_2_6_6_1
  doi: 10.1111/bjh.12432
– ident: e_1_2_6_13_1
  doi: 10.1056/NEJMoa1515319
SSID ssj0013051
Score 2.380245
Snippet Summary Progressive cytopenia is a serious complication among paediatric patients with inherited bone marrow failure syndromes (IBMFS). Androgens have been...
Progressive cytopenia is a serious complication among paediatric patients with inherited bone marrow failure syndromes (IBMFS). Androgens have been used to...
SourceID proquest
pubmed
crossref
wiley
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 976
SubjectTerms Adolescent
Adult
Androgens
Androgens - adverse effects
Androgens - therapeutic use
Bone marrow
bone marrow failure
Bone Marrow Failure Disorders - blood
Bone Marrow Failure Disorders - drug therapy
Bone Marrow Failure Disorders - genetics
Bone Marrow Failure Disorders - therapy
Canada - epidemiology
Cell Lineage
Child
Child, Preschool
Combined Modality Therapy
danazol
Danazol - adverse effects
Danazol - therapeutic use
Disease Progression
Drug Substitution
dyskeratosis congenita
Fanconi anaemia
Female
Hematology
Hematopoietic Stem Cell Transplantation
Humans
Infant
Male
Middle Aged
Oxymetholone - adverse effects
Oxymetholone - therapeutic use
Pancytopenia - drug therapy
Pancytopenia - etiology
Registries
Thrombocytopenia - drug therapy
Thrombocytopenia - etiology
Toxicity
Treatment Outcome
Virilism - chemically induced
Title Androgen therapy in inherited bone marrow failure syndromes: analysis from the Canadian Inherited Marrow Failure Registry
URI https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fbjh.16445
https://www.ncbi.nlm.nih.gov/pubmed/32128787
https://www.proquest.com/docview/2409638415
https://www.proquest.com/docview/2371144244
Volume 189
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LS8QwEB7Eg3jx_VhfRPHgZZfaJN2snnwtq7AeRMGDUNI09d0Vd_egv96ZNK1vEGkphSZt2slMvjQz3wBsKmlUaClrQJqpuuCZrCuttulghDI8VS7HUvc06lyIk0t5OQK7ZSxMwQ9R_XAjzXD2mhRcJ_0PSp7c3TQQ6wsKMN_mEfHmH56F7ysIgfTZ8ppoaoTyrELkxVPV_DwWfQOYn_GqG3Dak3BVNrXwM7lvDAdJw7x-YXH857tMwYQHomyv6DnTMGLzGRjr-qX2WXghV8cedi9WhGi9sNscdwoXRJDKkl5u2aNjcGSZviXndlayH_R3mPZcJ4zCV-gOrKRBYMfVPbpF9bavfmavXeq5ObhoH50fdOo-T0PdcKXISc6E2CGbmcyC1LQkTrlMylHOUaCjqBlmPMrSloiSNCUGOy6SEAWmydbaQLUkn4fRHFu9CExmxojQWpkGSiDW0FoE1ogItxCvBTXYKiUWG09iTrk0HuJyMoOfMnafsgYbVdGngrnjp0Irpdhjr7z9GEEOmSWENjVYry6j2tFais5tb4hleBNnkhQlWIOFortUT-EIBxQaQmysE_rvj4_3TzruZOnvRZdhPKQ5v_sTtAKjg-ehXUVgNEjWnAa8AYPvCIQ
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ZS8QwEB48QH3xPtYzig--7FKbpJsVX1Rc1mN9EAVfpLRp6t0V3X3QX-9MmtYbRCil0KRNO5nJl2TmG4B1JbXyDWUNSFJVFTyVVRWpTTppoTRPlM2x1D4JWufi8EJe9MF2EQuT80OUC26kGdZek4LTgvQHLY9vr2sI9oXsh0G7P0eQ6NR_30PwpMuXV0djI5TjFSI_nrLq59HoG8T8jFjtkNMcg8uisbmnyV2t141r-vULj-N_v2YcRh0WZTt555mAPpNNwlDb7bZPwQt5O3awh7E8SuuF3WR4UMQg4lQWdzLDHiyJI0ujG_JvZwUBwvMWixzdCaMIFnoCK5gQ2EH5jHZevemqn5orm31uGs6b-2d7rapL1VDVXCnyk9M-9sl6KlMv0Q2Jsy6dcBR14EVBUPdTHqRJQwRxkhCJHRexv8mDiMyt8VRD8hkYyLDVc8BkqrXwjZGJpwTCjSgSntEoYJwp4T2vAhuFyELteMwpncZ9WMxn8FeG9ldWYK0s-piTd_xUaLGQe-j09zlEnEOWCdFNBVbL26h5tJ0SZabTwzK8jpNJChSswGzeX8q3cEQECm0hNtZK_ffXh7uHLXsx__eiKzDcOmsfh8cHJ0cLMOLTEoBdGFqEge5TzywhTurGy1Yd3gAH8gyi
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3dT9RAEJ8gJMQXBFQ4RVyND77cpXQ_bg-fELgc4BFDJOHBpGn3Q1HoXby7B_jrndluCygmhrRpmuxuu-3uzP52d-Y3AO-0NDp1FDXAet0W3Mu2zvUWXYzQhlsdYiwNj9XgVByeybM5-FD7wlT8EM2CG0lG0Nck4GPrbwl58eN7B7G-kI9gQSgcJgkRnaQ3WwiJjOHyuqhrhI60QmTG0xS9Oxj9hTDvAtYw4vSfwNe6rpWhyc_ObFp0zPUfNI4P_JhlWIpIlO1UXWcF5ly5CovDuNf-FK7I1nGE_YtVPlpX7LzEk_wFEaWyYlQ6dhkoHJnPz8m6ndX0B5NtlkeyE0b-K_QEVvMgsIPmGcOqeD8WP3HfQuy5Z3Da3_-yO2jHQA1tw7UmKzmTYo_seukTa3oS51zGcmxoleRKdVPPlbc9oQpricKOiyLd4ionZesS3ZP8OcyXWOt1YNIbI1LnpE20QLCR5yJxRig8UkxLWvC-brHMRBZzCqZxkdWzGfyVWfiVLXjbZB1X1B33Zdqomz2L0jvJEOWQXkJs04I3TTLKHW2m5KUbzTAP7-JUktwEW7BWdZfmLRzxgEZNiJUNjf7v12cfDwfh5sX_Z30Ni5_3-tmng-Ojl_A4pfl_WBXagPnpr5l7hSBpWmwGYfgN26kLUQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Androgen+therapy+in+inherited+bone+marrow+failure+syndromes%3A+analysis+from+the+Canadian+Inherited+Marrow+Failure+Registry&rft.jtitle=British+journal+of+haematology&rft.au=Catal%C3%A0%2C+Albert&rft.au=Ali%2C+Salah+S.&rft.au=Cuvelier%2C+Geoffrey+D.+E.&rft.au=Steele%2C+MacGregor&rft.date=2020-06-01&rft.issn=0007-1048&rft.eissn=1365-2141&rft.volume=189&rft.issue=5&rft.spage=976&rft.epage=981&rft_id=info:doi/10.1111%2Fbjh.16445&rft.externalDBID=10.1111%252Fbjh.16445&rft.externalDocID=BJH16445
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0007-1048&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0007-1048&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0007-1048&client=summon